|
CanasaDrug - Canasa The trade name of the product as shown on the labeling.
Dosage -
SUPPOSITORY; RECTAL
Active Ingredient(s) -
Mesalamine
Strength -
1GM
Applicant -
AXCAN SCANDIPHARM
New Drug Application (NDA) Number -
021252
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Nov 5, 2004
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Axcan Scandipharm Inc
Canasa
Pentasa 250mg Capsule, Extended Release; Oral
Pentasa 500mg Capsule, Extended Release; Oral Mesalamine 4gm/60ml Enema; Rectal Mesalamine 4gm/60ml Enema; Rectal Rowasa 4gm/60ml Enema; Rectal Canasa 1gm Suppository; Rectal Mercaptopurine 50mg Tablet; Oral Merrem I.V. 1gm/vial Injectable; Injection Merrem I.V. 500mg/vial Injectable; Injection Mersalyl-theophylline 100mg/ml;50mg/ml Injectable; Injection NewDrugInformation |